This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Kimihiro Shirai: Innovator in Pyrazolo[1,5-A]pyrimidine Compounds
Introduction
Kimihiro Shirai is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrazolo[1,5-a]pyrimidine compounds. His research has the potential to impact various therapeutic applications.
Latest Patents
Kimihiro Shirai holds 1 patent for his invention related to pyrazolo[1,5-a]pyrimidine compounds. The patent describes a novel compound of the formula [I], where R and R' can be the same or different and may include an optionally substituted aryl group. This invention showcases his expertise in chemical compounds and their applications in medicine.
Career Highlights
Shirai is currently associated with Mitsubishi Tanabe Pharma Corporation, a leading pharmaceutical company. His role there allows him to further his research and development efforts in the pharmaceutical industry. His work is instrumental in advancing the company's innovative drug development initiatives.
Collaborations
Kimihiro Shirai collaborates with esteemed colleagues such as Yasunori Moritani and Mariko Oi. These partnerships enhance the research environment and foster innovation within their projects.
Conclusion
Kimihiro Shirai is a prominent figure in the field of pharmaceutical innovation, particularly known for his work on pyrazolo[1,5-a]pyrimidine compounds. His contributions continue to shape the landscape of drug development and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile